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A framework for fetecting interactions between co-incident clinical processes 
Abstract 
The detection of treatment conflicts between multiple treatment protocols that are co-incident is a 
difficult and open problem that is particularly exacerbated regarding the treatment of multiple medical 
conditions co-occurring in aged patients. For example, a clinical protocol for prostate cancer treatment 
requires the administration of androgen-suppressing medication, which may negatively interact with 
another, co-incident protocol if the same patient were being treated for renal disease via haemodialysis, 
where androgen-enhancers are frequently administered. These treatment conflicts are subtle and difficult 
to detect using automated means. Traditional approaches to clinical decision support would require 
significant clinical knowledge. In this paper, the authors present an alternative approach that relies on 
encoding treatment protocols via process models (in BPMN) and annotating these models with semantic 
effect descriptions, which automatically detects conflicts. This paper describes an implemented tool 
(ProcessSEER) used for semantic effect annotation of a set of 12 cancer trial protocols and depicts the 
machinery required to detect treatment conflicts. The authors also argue whether the semantic effect 
annotations of treatment protocols can be leveraged for other tasks. 
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INTRODUCTION
The notion of 3;%!0@=$#) <;2;8!<!25 (Pan-
>3$373.)?366@.)A83&1%5%.)B%7(3$%5%.)C)D(9;35911%.)
2002) has become the focus of considerable 
$9793$:')3((95(%!5)%5)('9)$9:95()"37(4)/()28%167)
on the premise that process management 
principles and techniques can deliver value in 
A Framework for Detecting 


















clinical settings as much as it delivers value in 
79((%5&7)78:')37)287%5977)"$!:977)<353&9<95(4)
Clinical process management can help encode 
clinical guidelines which can provide a refer-
95:9)23791%59);!$):1%5%:%3574)E'979):35)19F9$3&9)
the coordination capabilities of process engines 
%5)9578$%5&)('3() ($93(<95()7(9"7)3$9)9G9:8(96)
:!$$9:(1#)$913(%F9)(!)$9;9$95:9)&8%691%5974)?!$9)
generally, care-flow management also addresses 
the administrative aspects of health care, both 
HI/J)-,4K,-LMN9'<:4+,-,,K,-,O
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from the perspective of health care providers 
356)"3(%95(7)P 8$$#.)?:0$9&!$.)C)E$3:9#.)+,,QR4
SG%7(%5&)(9:'5%T897M5!(3(%!57);!$)<!691-
ling processes, such as the industry-standard 
Business Process Modelling Notation (BPMN) 
PI?0.) +,,QR.) !51#) <!691) ('9) :!!$6%53(%!5)
semantics of processes, but offer no facility for 
describing the effects of processes (or steps/
3:(%F%(%97)=%('%5)"$!:97797R4)E'87.)=9)3$9)3219)
to clearly specify the required sequencing of 
activities, for instance, but cannot specify the 
effects that these activities would have on the 
6!<3%5M:!5(9G() %5) ='%:') ('9) "$!:977) =!816)
9G9:8(9)P29#!56)('9)<%5%<31)%5;!$<3(%!5)('3()
:35)29):!5F9#96)F%3)('9)5!<95:13(8$9)!;)(37U7R4)
However, these effect descriptions are critical 
in determining whether process designs have 
2995):!$$9:(1#) ;!$<813(964)V7)=911.)<8:')!;)





a business process life cycle (Koliadis, Vrane-
79F%:.)Y'8%#35.)W$%7'53.)C)0'!79.)+,,QR)$91%97)
on being able to refer to the effect semantics of 
287%5977)"$!:977974
In this paper, we leverage a technique (and 
78""!$(%5&)(!!1)Z)B$!:977DSS[R)P\%5&9.)0'!79.)
C)W!1%36%7.)+,,]R)('3()"$!F%697)3)"$3:(%(%!59$Z
accessible means for providing semantics effect 
annotations of process models to deliver value 
in clinical process management in a range of 
6%;;9$95()=3#74)̂ 9);!:87)"$%<3$%1#)!5)('9)879)!;)
this machinery in detecting treatment conflicts 
29(=995):!Z%5:%695()($93(<95()"$!(!:!17.)%494.)
situations where the application of a treatment 
protocol on a patient contra-indicates the ap-
plication of another treatment protocol on the 
73<9)"3(%95(4)E'979)3$9)!;(95)782(19.)356)!('9$-
=%79)6%;;%:81()(!)69(9:()87%5&)38(!<3(96)<93574)
We also argue that semantic effect annotations 
of treatment protocols can be leveraged for a 
variety of other tasks, including identifying 
instances where different specialists arrive at 
differing interpretations of the same protocol, 
37)=911)37)"963&!&%:31)3""1%:3(%!574
The language in which these effects need 
to be specified should ideally be formal, permit-
ting sophisticated tool support for several of the 
3531#7%7)356)$937!5%5&)(37U7)<95(%!596)32!F94)
Formal languages are typically not practitioner-
accessible while informal annotations make 




ing the analyst a repertoire of sentence schemas 
in which to describe the effects - populating a 
sentence schema generates a correspondingly 
%57(35(%3(96);!$<31)355!(3(%!54)E!)3F!%6)"13:%5&)
an unduly heavy burden of annotation on ana-
lysts, our approach only requires that analysts 
provide a description of the immediate effects 
!;)93:')"$!:977)(37U.)%494.)3):!5(9G(Z%569"95695()
specification of the functionality (together with 
$919F35()377!:%3(96)$3<%;%:3(%!57R)!;)93:')(37U4)
These are then accumulated into 37<7=;54D!)
effect annotations)%5)3):!5(9G(Z7957%(%F9)<35-
ner, such that the cumulative effect annotations 
associated with any task in a BPMN process 
model would describe the effects achieved by 
('9)"$!:977)=9$9)%()(!)9G9:8(9)8")(!)('3()"!%5(4)
We note that such a description will necessarily 
29)5!5Z69(9$<%5%7(%:.)%494.)('9$9)<%&'()29)31(9$-




taken different paths through a process model to 
3$$%F9)3()3):9$(3%5)"!%5(4)D9:!56.)('9)9;;9:(7)!;)
certain process steps might “undo” the effects 
!;)"$%!$)"$!:977)7(9"74)E'%7)%7)!;(95)697:$%296)37)
the belief update or O2$#=!&8!)7>&;5! problem 
- multiple alternative means of resolving the 
inconsistencies generated by the “undoing” of 
9;;9:(7)%7)35!('9$)7!8$:9)!;)5!5Z69(9$<%5%7<4
After reviewing relevant background in 
Section 2, we summarise key elements of the 
B$!:977DSS[);$3<9=!$U)P\%5&9)9()314.)+,,]R)
for semantic effect annotation of process 
<!6917)%5)D9:(%!5)O4)/5)D9:(%!5)K.)=9)697:$%29)
the machinery for detecting conflicts between 
:!Z%5:%695():1%5%:31)"$!:977974)/5)D9:(%!5)b.)=9)




of the capabilities of the framework, followed 
by some brief comments on evaluation, and 
:!5:187%!574
BACKGROUND
Clinical Process/Care-flow Management: 
The notion of 3;%!0@=$#) <;2;8!<!25 (Pan-
>3$373)9()314.)+,,+R)'37)29:!<9) ('9) ;!:87)!;)
considerable research attention in the recent 
"37(4)/()28%167)!5)('9)"$9<%79)('3()"$!:977)<35-
agement principles and techniques can deliver 
F3189)%5)95:!6%5&)P356):!!$6%53(%5&)9G9:8(%!5)
F%3) "$!:977) 95&%597R) !;) :1%5%:31) &8%691%5974)
More generally, care-flow management also 
addresses the administrative aspects of health 
care, both from the perspective of health care 
"$!F%69$7) 356) "3(%95(7) P 8$$#) 9() 314.) +,,QR4)
Clinical procedures are performed by a variety 
of clinicians and treatments are often prescribed 
38(!5!<!871#4)SF95)=%(')('9)3285635:9)!;)(9G(Z
based documentation on medical procedure it 
can be difficult to identify potential conflicts 
29(=995)($93(<95(74)B3(%95()$9:!$67)<3#):!5(3%5)
3)78<<3$#)!;)9G%7(%5&)356)"37()($93(<95(7)28()
lack certain details that could impact on future 
!$):!5:8$$95()($93(<95(7)%;)8569(9:(964)\3F%5&)
('%7)(9G(Z23796)6!:8<95(3(%!5)6!97)5!()&83$35-
tee that it will be used whereas computer-based 
patient-specific reminders that are integrated 
%5(!)('9):1%5%:%35c7)=!$U);1!=)'3F9)"$!F95)(!)
29);3$)<!$9)9;;9:(%F9)PD(9;35911%.)+,,+R4
Care-flow processes are often represented 
in a diagrammatical format that provides a vi-
sually intuitive representation of the activities 
$9T8%$96)(!)($93()3)"3(%95(c7):!56%(%!54)V1('!8&')
"$!:977)<!6911%5&)'37)2995)8796)9G(957%F91#)%5)
the business community it is a relatively new 
%55!F3(%!5)=%('%5)('9)'931('):3$9)%5687($#4)H9-
7:$%296)%5) 8$$#)9()314)P+,,QR)%7)3)(!!1)('3()8(%1%797)
Workflow Reference Models (Hollingsworth, 
-]]bR)(!)F%7831%79)3)"3(%95(c7)N!8$59#)('$!8&')3)
\931(') 3$9)I$&35%73(%!5)P\ IR4)E'9)<!6917)
prove to be particularly useful for encourag-
ing group communication within a HCO and 
promoting ownership and responsibility among 
3:(%F9) "3$(%:%"35(7) %5F!1F96) %5) ('9) "$!:9774)
The models are particularly good for training 
purposes because they visually translate much 
937%9$)('35)3)(9G()6!:8<95(4
The integration of Care-flow Management 
D#7(9<7)P ?DR):35)&$93(1#)%<"$!F9)3)"3(%95(c7)
N!8$59#)('$!8&')('9)'931('):3$9)7#7(9<4) ?D7)
can be used in a variety of ways, as control 
mechanisms to constrain the operations of health 
care workers to predefined treatment protocols 
P 8$%3.)03118::%.)C)[8;;!1!.)+,,bR.)37)69:%7%!5)
support mechanisms that assist clinicians with 
"$97:$%2%5&)($93(<95()"$!(!:!17)P?3G%<%5%)C)
D:'33;.)+,,OR)356)37):95($31)$9"!7%(!$%97);!$)('9)
comparison and analysis of different treatment 
"$!(!:!17)P[8;;!1!.)?3553.) !>>3.)C)d$7%5!.)
+,,XR4)I;)('979)('$99)!51#)P[8;;!1!)9()314.)+,,XR)
addresses the need for internet compatibility 
so that stored information may be accessed by 
35#)\ I4)E'%7)%7)"3$(%:813$1#)%<"!$(35()&%F95)
('3()3)"3(%95(c7)N!8$59#)('$!8&')('9)'931('):3$9)
system will place them in the hands of many 
38(!5!<!87) \ I74) /5(9$59() 3::977) (!) !('9$)
38(!5!<!87)\ I7c)($93(<95()"$!(!:!17)=!816)
greatly assist clinicians with the prescription 
!;)('9%$)!=5)($93(<95(7)PV5>2e:U)C)H87(63$.)
+,,KR4







here corresponds most closely to ‘Prescribing 
H9:%7%!5) D8""!$() D#7(9<7c.) 356) (!) 3) 19779$)
69&$99)(!)fV19$(7)356)[9<%569$7c)356)fE'9$3"#)
 $%(%T8%5&)356)B1355%5&c4
Business Process Modelling Notation: 
The Business Process Modelling Notation 
PYB?_R) PI?0.) +,,QR.) 7(3563$6%796) 2#) ('9)
I2N9:()?353&9<95()0$!8")PI?0R)%5)a92$8-
ary 2006 was motivated be a need to develop 
a modelling notation that could bridge the gap 
between process design and process implemen-
(3(%!5)356)($35713(9)937%1#)%5(!)9G9:8(3219):!69.)
5!(321#)Y87%5977)B$!:977)SG9:8(%!5)̀ 35&83&9)
;!$) 9̂2) D9$F%:97) PYBS`K^DR4)^'%19) !('9$)
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modelling notations have proven effective at 
modelling programming code artifacts, in the 
:379)!;)d5%;%96)?!6911%5&)`35&83&9)Pd?`R)
PI?0.)+,,]R.)!$)"$!F%6%5&)35)%5(8%(%F9)F%7831)
representation for describing a process, in the 
case of a Workflow Diagram produced in Mi-
crosoft Visio, BPMN has combined both these 
3(($%28(97)%5(!)3)7%5&19)5!(3(%!54)V)YB?_)<!691)
can therefore be used as a visual instructional 
tool for human consumption and as a template 
;!$)38(!<3(96):!69)&959$3(%!54)^'95)"$!:977)
segments are identified for automation then a 
programmer can use the BPMN model to au-
(!<3(%:311#)&959$3(9):!694)E'%7)%7)35)%<"!$(35()
economic consideration when planning for 





Semantic Process Management: Anno-
tating and analysing specifications of program 
functionality, in order to help establish program 
correctness, has a long tradition dating back to 
('9) %5($!68:(%!5) !;) ('9) 3G%!<3(%:) (9:'5%T897)
"$!"!796)2#)\!3$9)356)H%NU7($3)P\8(')C)[#35.)
+,,KR4)̂ %(')78;;%:%95()%5;!$<3(%!5.)('979);!$<7)
of annotations provide (Shanahan, 1997) a basis 
for answering questions relating the identifica-
tion of: the conditions enabling a process to be 
"9$;!$<96)P%494.)"!7(6%:(%!5Rg)('9):!56%(%!57)$9-
sulting from a process being performed in some 
:!5(9G()P%494.)"$96%:(%!5Rg)356.)('9)"$!:97797)=%(')
the capability of realising a set of conditions 
='95)9G9:8(96)%5)7!<9):!5(9G()P%494.)"1355%5&R4)
Recently, similar proposals have emerged in the 
6!<3%5)!;)=92)79$F%:97)P?:/1$3%('.)D!5.)C)h95.)
+,,-R)P?3$(%5)C)H!<%5&89.)+,,XR4)E'979);!$<7)
of specification can be effective for performing 
analyst related tasks, however their utility and 
availability in some situations can be limited 
P94&4.) :!7() $97($%:(%!57R) Z) =3$$35(%5&) 3) 5996)
for “partiality” and “lightweight” approaches 
Pi3:U7!5)C)^%5&.)-]]QR4)E'9):!5($%28(%!5)%5)
this paper are techniques to leverage a partial 
specification of functional effects annotated to 
287%5977)"$!:977)<!69174
A lot of effort is currently being directed 
into semantic annotation for web service or 
"$!:977)6%7:!F9$#4)[9:95(1#.)3)79<35(%:)355!-
tation framework was developed to facilitate 
the interchange of process models and their 
6%7:!F9$#)P`%5.)+,,LR4)I5(!1!&%97)3$9)8796)%5)
this framework as a classification repository for 
the identification of processes or sub-processes 
('3()73(%7;#)('9)7919:(%!5):$%(9$%34)I8$)(!!1)=%11)
$968:9)('9)$%7U)!;)<!6%;#%5&)9G%7(%5&)"$!:97797)
by alerting the analyst to the consequences of 
697%&5) (%<9) 69:%7%!574) 9̂) 879) !5(!1!&%97) %5)
:!5N85:(%!5)=%(')3) _`)(3G!5!<#)(!)69;%59)
the vocabulary used in the effect annotations 
;!$)('9)"8$"!79)!;)($35713(%!5)%5(!);!$<31)1!&%:4)
I8$)"$!:977)6%;;9$7);$!<)('3()697:$%296)%5)P`%5.)
2008) in that effect annotations are not simply 






These notions of state and stability lead to a 
general notion of validity of process models 
P"$%<3$%1#)=4$4(4)&!31)$93:'32%1%(#R4)/5)PD!;;9$.)
+,,bR.)('9)0B?)%7)8796)37)3)237%7);!$)%695(%;#-
ing the scope of changes that can be made to an 
9G%7(%5&)"$!:977)&%F95):'35&97)(!)0B?Z$913(96)
"'95!<953) P94&4.) &!31) :'35&9R4)D!<9)!;) ('9)
techniques outlined in this paper, such as the ac-
cumulation procedure, help leverage partial and 
symbolic state descriptions to perform goal and 
:'35&9)$919F35()3531#7%74)/5)('9)DYBj)3""$!3:')
P 9̂29$.)\!;;<35.)C)?9561%5&.)+,,LR.)3)7:'9<9)
for annotating and propagating a restricted form 
!;) 3G%!<3(%:) (37U) 697:$%"(%!57) %7) %5($!68:96)





specifications of tasks in the BPMN model) and 
is driven by the need to identify the minimal 
amount of semantic annotation required to 
meet the requirements of functions such as 
compliance management, process change and 
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life-cycle management, enterprise process 
3$:'%(9:(8$97)9(:4)E'9)DYBj)3""$!3:'.)!5)('9)
other hand, requires complete specifications of 
both pre-conditions and post-conditions that are 
:!5(9G(Z7957%(%F9.)('87)"13:%5&)3)7!<9='3()!59$-
ous burden on the analyst (besides additional 
annotations required for reachability analysis, 
='%:')=9)6!)5!():!57%69$R4)I8$)<3:'%59$#);!$)
:!5(9G(831%7%5&):!5(9G(Z%569"95695()(37U)9;;9:()
specifications provided by analysts solves a 
harder problem, by permitting non-determinism 
%5) 9;;9:() 7:953$%!74) 9̂) :!579T895(1#) :355!()
provide polynomial-time guarantees as the 
DYBj);$3<9=!$U):354)̂ 9)291%9F9)('%7)%7)5!()3)
significant impediment since design, annotation 
and propagation tasks do not normally involve 
$931Z(%<9):!57($3%5(7.)356)3;;!$6)('9)18G8$#)!;)
71!=9$)!;;Z1%59):!<"8(3(%!54)I8$)9F3183(%!5)'37)






allows practitioners to annotate semantic effects 
to process activities/tasks and performs on-
demand, anytime computation of cumulative 
9;;9:(74)E'9$9)3$9)(=!)7(3&97)(!)9;;9:()3::8<8-
13(%!54)E'9) ;%$7() 7(3&9) %5)9;;9:()3::8<813(%!5)
involves deriving a scenario labelP0'!79)C)
Koliadis, 2008) which provides the organising 
1!:87);!$)!8$)"$!:968$94)a!$)!2(3%5%5&)('9)9;;9:()
scenario at a given point in a process we com-
"8(9)('9)79()!;)7:953$%!)132917)3()('3()"!%5(4)V)
scenario label is a precise list of tasks that define 
a path leading from the Start Event in a model 
(!)('9)7919:(96)(37U4)E'9)7%<"197();!$<)!;)7:9-
53$%!)13291)%7)3)79T895:9)!;)(37U74)a!$)9G3<"19.)
〈 〉S T G T G T, , , , ,
1 1 2 2 6
 is a scenario label where 
S )%7)('9)7(3$()9F95(4)V)7:953$%!)13291):35)9%('9$)
be a sequence, denoted by the 〈〉  delimiters, or 
a set denoted by the {}  delimiters or combina-
(%!57)!;)2!('4)E'9)79()691%<%(9$7)3$9)8796)(!)6931)
with parallel splits, and distinct elements in a 
79():35)29)"9$;!$<96)%5)35#)!$69$4
The second stage of effect accumulation 
involves the processing of immediate effect 
annotations for each of the tasks listed in the 
scenario label using a pair-wise operation where 
the immediate effect of S  is combined with 
the immediate effect of T
1
, the result being the 





 is then combined with the immediate 
effect of T
2
 resulting in the cumulative effect 
at T
2
 and so on up to T
n
4
/$25487$7'):;'O'( We define a process for 
pair-wise effect accumulation, which, given an 
ordered pair of tasks with effect annotations, 
determines the cumulative effect after both tasks 
'3F9)2995) 9G9:8(96) %5) :!5(%&8!87) 79T895:94)
9̂) 3778<9) ('$!8&'!8(.) ('9) 9G%7(95:9) !;) 3)







, such that T
2
 somehow “un-
does” the effects of T
1
 or changes the status of 
some entity referred to in T
1
4)a!$)%57(35:9.)('9)
status of a cheque submitted in T
1
 might be 
“not yet cleared”, while the immediate effect 
of the “cheque clearance” task T
2
 might be to 
79()%(7)7(3(87)(!)k:193$96l4)V)23:U&$!856)$819)
that specifies that a cheque cannot have a 
“cleared” and “not yet cleared” status simulta-
neously ensures that we do not counter-intui-
tively obtain both status descriptions in the 
73<9)9;;9:()7:953$%!4
The procedure serves as a methodology 
for analysts to follow if only informal annota-
(%!57)3$9)3F3%132194) 9̂)3778<9)('3()('9)9;;9:()
355!(3(%!57)'3F9)2995)$9"$9795(96)%5):!5N85:-
tive normal form (CNF) where each clause is 
also a prime implicate)P[38()C)D%5&'.)+,,KR)
P('%7)"$!F%697)3)5!5Z$9685635():35!5%:31);!$<R4)




795(95:97) %5(!) ('9) :!5N85:(%F9) 5!$<31) ;!$<.)
and for obtaining the prime implicates of a 
('9!$#) P$9;9$95:97) !<%((96) ;!$) 2$9F%(#R4) `9()
T T
i j
,  be an ordered pair of tasks connected 











 be the immediate effect annotation as-
sociated with T
j
4)̀ 9()e c c c
i i i im
= …{ }1 2, , ,  and 
e c c c
j j j jn
= …{ }1 2, , ,  (we can view CNF sen-
tences as sets of clauses, without loss of gen-
9$31%(#R4)/;)e e
i j
  is consistent, then the result-
ing cumulative effect, denoted by acc e e
i j
( , ) , 
is e e
i j
 4)S179.)=9)69;%59) e e
i i′
⊆  such that 
e e
i j′
∪ ) %7) :!57%7(95() 356) ('9$9) 9G%7(7) 5!) e
i !!
 
such that e e e
i i i′ ′′
⊂ ⊆  and e e
i j′′
∪  is consis-
(95(4) 9̂)69;%59)acc e e e e
i j i j
( , )= ∪
′
4) 9̂)5!(9)
that acc e e
i j
( , ) ) %7) 5!5Z85%T89) %494.) ('9$9) 3$9)




effect of the two tasks consists of the effects of 
the second task plus as many of the effects of 
('9);%$7()(37U)37):35)29):!57%7(95(1#)%5:186964)
We remove those clauses in the effect annota-




In the preceding, we assume that all con-
sistency checks implicitly include a background 
knowledge base (KB) containing rules and 
3G%!<74) E'87.) ('9) 7(3(9<95() ('3() e e
i j′
∪  is 
consistent, effectively entails e e KB
i j′













 in a process model 
where T
2






an effect scenario, while e
2
 represents an im-
<96%3(9)9;;9:()355!(3(%!54)V()T
1
 the cumulative 
effect is ( )p q  and the immediate effect of 
T
2
 is r  !"! #$%&! &'()*)! (+! *,&!-.! *,/*! )*/*&)!
KB r p q= → ¬ ∧( )  
e p q
1




KB r p q= → ¬ ∧( )  
¬ ∧ ≡ ¬ ∨¬( ) ( )p q p q  
Applying the definition above, the two 
alternative effect scenarios describing the cu-
mulative effects at T
2
 are { , }p r  and { , }q r  
In addition to pair-wise effect accumulation 
across scenario labels, we need to make special 
provision for the following: (1) accumulation 
/0#1))! "23451(+)6! /+7! 89:! /00$;$%/*(1+! 1<!
&<<&0*)! 1=&#! ;&))/>&! <%1?)! 8&'*&+7(+>! *,&!
<#/;&?1#@! A#&)&+*&7! (+! 8B,1)&! C! -1%(/7()6!













,  and E
jm
 
be the set of cumulative effect scenarios associ-
ated with T T
h in
,  and T
jm
!#&)A&0*(=&%I !J,&!)&*!
of cumulative effect scenarios associated with 
T
i1
 is given by  !K(;(%/#%I6!
the set of cumulative effect scenarios associ-
ated with T
j1








 as if they constitute a con-
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scenarios associated with T
h
 is given by 
{ ( , ) ( , ) ,acc es e acc es e es E es E
i k j k i in j jm
∪ ∈ ∈  
and es es
i j
, ! /#&! &'0%$)(1+401;A/*(G%&}  ! L+!
other words, we pair-wise accumulate the im-
mediate effect of T
k
 with each effect scenario 
1<!&/0,!1<!*/)@)!A#&0&7(+>!*,&!"23451(+6!G$*!
then combine them via set union since every 
possible combination of the prior scenarios 
01$%7!A1*&+*(/%%I!*#/+)A(#& ! !"#$%&'()"'*+,--
ibility provides a guarantee that the effect 
)0&+/#(1)!01$%7!A1*&+*(/%%I!100$#!*1>&*,&#6!( & 6!
*,/*! *,&I! 71! +1*! ,/=&! /! ;$*$/%%I! &'0%$)(=&!
(XOR) split in their antecedents relative to each 
1*,&# ! P'0%$)(1+401;A/*(G(%(*I! ()! 7&*&#;(+&7!
using the .!"#$/.)%.- mechanism described in 
*,&!+&'*!)&0*(1+ !21*&!*,/*!?&!71!+1*!01+)(7&#!





 being inconsistent, since this would 
only happen in the case of intrinsically and 
obviously erroneously constructed process 
;17&%) 
Much of the earlier and following discus-
)(1+!A&#*/(+)!*1!<%1?)!?(*,(+!(+7(=(7$/%!A11%) !
Message flow links across pools can be dealt 
with in a relatively straightforward fashion 
by requiring an immediate effect annotation 
<1#!&/0,!(+01;(+>!;&))/>& !J,&)&!&<<&0*)!/#&!
01;G(+&7!=(/!01+5$+0*(1+!?(*,!*,&!(;;&7(/*&!
effects of the task associated with the incoming 
;&))/>& !O&!/))$;&!/>/(+!*,/*!+1!(+01+)()*&+-
cies appear between the message and task ef-
fects - such inconsistencies would only appear 
(+!&##1+&1$)!A#10&))!7&)(>+) 
The procedure described above does not 
satisfactorily deal with loops, but we can per-
<1#;!/AA#1'(;/*&!0,&0@(+>!GI!A/#*(/%!%11A!$+-
#/=&%%(+> !K1;&!&<<&0*!)0&+/#(1)!>&+&#/*&7!$)(+>!
this approach might be infeasible, but we note 
*,/*!1$#!1G5&0*(=&!()!*1!7&=()&!7&0()(1+4)$AA1#*!
functionality in the compliance management 




In this section, we will discuss how the Process-
KPPQ!<#/;&?1#@!7&)0#(G&7!/G1=&!?/)!&'*&+7&7!
to address the problem of detecting interactions 
G&*?&&+!014(+0(7&+*!0%(+(0/%!A#1*101%) !J?1!@&I!
&'*&+)(1+)!,/=&!G&&+!;/7& !R(#)*6!?&!(+*#17$0&!
a distinction between mandatory effects and 
potential effects !K$0,!/!7()*(+0*(1+!()!01;;1+!
in clinical settings, for instance, between the 
(mandatory) intended effects of medication, and 
8A1*&+*(/%:!)(7&4&<<&0*)S01;A%(0/*(1+) !K&01+76!
we develop the machinery required to be able 
to detect conflicts between treatment protocols 
based on semantic effect annotation of clinical 
A#10&))!;17&%) 
The notion of scenario labels! 8B,1)&!C!
Koliadis, 2008) is central to the effect accu-
mulation procedure - these effectively describe 
the paths taken through a process model to 
obtain the corresponding effect scenarios (as 
/! )&T$&+0&! 1<! >/*&?/I! /+7! */)@! (7&+*(<(&#): !
This is important given that it is possible to 
arrive at a given task in a process model via 
;$%*(A%&! /%*&#+/*(=&! A/*,) ! "! )0&+/#(1! %/G&%!
also includes an .!"#$/.0%.- - these are used to 
ensure that effects from paths that are mutually 
&'0%$)(=&!81#(>(+/*(+>!(+!UVQ4)A%(*):!/#&!+1*!
01;G(+&7 !O&!&'*&+7! *,&!+1*(1+!1<! )0&+/#(1!
label in this work to include the applicable 
condition for a scenario - this is represented 
/)! *,&! 01+5$+0*(1+! 1<! 01+7(*(1+)! /))10(/*&7!
with the (labelled) outgoing flows from each 
OR- or XOR-split gateway preceding the task 
?(*,!?,(0,!*,()!)0&+/#(1!()!/))10(/*&7 !L+!*,&!
&=&+*!*,/*!*,()!01+5$+0*(1+!()!$+)/*()<(/G%&!8*,()!
is unlikely, but possible) this condition will be 
&;A*I!8( & 6!*,&!%1>(0/%!JQWP!=/%$&: !J,&!+1-
tion of an applicable condition associated with 
an effect scenario helps us identify situations 
where certain treatment steps are unlikely to 
logically co-occur in the instance of the same 
patient, because of contradictory applicable 






O&! /))$;&! *,&! &'()*&+0&! 1<! /! patient-
%+."&1&"02('3#./4.)5,%. (P-KB) as well as a 
5,"246'$(/02('3#./4.)5,%. (B-KB), but the 
techniques we present can be of use even when 
*,&)&! /#&! &;A*I! 8/)! *,&! &'/;A%&! (+! *,&! +&'*!
)&0*(1+! (%%$)*#/*&): ! J,&! &(-.6,"-&'()"7."2&(40
mechanism takes as input a set of semantically 
annotated clinical process models of the form 
7()0$))&7!/G1=&6!/+7!/!X4-. !L*!#&*$#+)!/!)&*!
of "'(1#&"-0 1#,4% if a potential conflict is de-
*&0*&7!G&*?&&+!*,&!(+A$*!A#10&))&) !L+!*,&!<1%-
lowing, a conflict refers to situations where 
{ , , }es es P KB B KB
n1
… ∪ − ∪ −  is incon-
sistent, where each es
i
 represents an effect 
scenario obtained from a distinct process that 
()! A/#*! 1<! *,&! (+A$* ! 21*&! *,/*! ?,&+! 01+<%(0*!
0,&0@(+>!;$)*!G&!#&)*#(0*&7!*1!;/+7/*1#I!8#&)A !
A1*&+*(/%:!&<<&0*)6!?&!0/+!7(#&0*%I!&'*#/0*!*,&)&!
components from an effect scenario (since each 
/))&#*(1+!(+!/+!&<<&0*!)0&+/#(1!()!*,$)!%/G&%%&7: !
Conflict flags can be of various kinds:
Y! 8-6'(40"'(1#&"-%9 These involve situations 
where all effect scenarios associated with 
a task in one process conflict with all the 
effect scenarios associated with a task in 
/!7()*(+0*!A#10&)) 
Y! :.,20"'(1#&"-%9 These involve situations 
where some (but not all) effect scenarios 
associated with a task in one process con-
flict with some (but not all) effect scenarios 
/))10(/*&7!?(*,!/!*/)@!(+!/!7()*(+0*!A#10&)) 
Y! ;,(/,-'6<);,(/,-'6<0=;;>0.11."-0"'(-
flicts: These involve situations where the 
mandatory effects within an effect sce-
nario associated with a task in one process 
conflict with the mandatory effects in an 
effect scenario associated with a task in a 
7()*(+0*!A#10&)) 
Y! ;,(/,-'6<)?'-.(-&,#0=;?>0.11."-0"'(1#&"-%9 
These involve situations where the manda-
tory effects within an effect scenario associ-
ated with a task in one process conflict with 
the potential effects in an effect scenario 
/))10(/*&7!?(*,!/!*/)@!(+!/!7()*(+0*!A#10&)) 
Y! ?'-.(-&,#)?'-.(-&,#0 =??>0.11."-0"'(1#&"-%9 
These involve situations where the potential 
effects within an effect scenario associated 
with a task in one process conflict with 
the potential effects in an effect scenario 
/))10(/*&7!?(*,!/!*/)@!(+!/!7()*(+0*!A#10&)) 
These categories provide a rich vocabulary 
for describing conflicts and are not mutually 
&'0%$)(=&!8?&!;/I!1G*/(+!/!)*#1+>!ZX!01+<%(0*!
1#!/!?&/@!XX!01+<%(0*: 
For each kind of conflict, we can further 
distinguish the severity of the problem by using 
the applicable condition associated with the ef-
<&0*!)0&+/#(1 !F1+<%(0*)!G&*?&&+!&<<&0*!)0&+/#(1)!
whose applicable conditions are consistent are 
%(@&%I!*1!G&!*,&!;1)*!)&=&#& !F1+<%(0*)!G&*?&&+!
effect scenarios whose applicable conditions are 
inconsistent are less likely, but still possible, 
given than the notion of an applicable condi-
*(1+!()!/!01/#)&!/AA#1'(;/*(1+!/+7!01+7(*(1+)!
associated with gateways might be transient in 
,(>,%I!7I+/;(0!A#10&))&) 
In the following section, we provide one 
)$G)*/+*(=&!&'/;A%&!1<!*,&!7&*&0*(1+!1<!*#&/*-
ment conflicts via semantically annotated 
A#10&))!;17&%) !P=&+!?(*,!*,()!)&**(+>6!*,&!)([&!
of the process models, and the effect annota-
tions makes it impossible to display the models 
(+!*,&(#!&+*(#&*I !J,&!01+<%(0*!<%/>!1G*/(+&7!(+!
this instance is a %-6'(40;;0"'(1#&"- !O&!0/+-
not illustrate the other categories of conflict 
due to space restrictions, but their should be 
+&=&#*,&%&))!G&!)&%<4&=(7&+* 
EXAMPLE
As part of this research program, we have initi-
/*&7!/!%/#>&4)0/%&!&'&#0()&!(+!A#10&))!;17&%%(+>!
8(+!*,&!.XZ2!+1*/*(1+:!1<!0%(+(0/%!A#1*101%) !
A total of twelve cancer trial protocols have 
G&&+!;17&%%&7!(+!.XZ2 !J,&!#&)$%*(+>!;17&%)!
are large, and after semantic effect annotation, 
%/#>&#!)*(%% !R(>$#&!9!7&)0#(G&)!/!);/%%!A1#*(1+!
of a prostate cancer trial protocol modelled in 





follows (we provide only the natural language 
version, and omit the formal version obtained 





blood count should be requested.
As part of the treatment of prostate cancer it 
is common to prescribe anti-androgen medica-
#/&0$#&$2)%!+)$'0%2&()0$-)5)-"$/0$#,)$4'#/)0#."$
6-&&%7$80$91/(!2)$:;$#,)$'+#/&0$&<$42)"+2/6/0($
an anti-androgen (Flutamide) is represented by 
'$#'"=*'+#/&0$/+&0$/0$'$>?@A$B&%)-7
A common step in a renal haemodialysis 
protocol (full BPMN model omitted here due 
to space restrictions) is the prescription of 
'0%2&()0C)0,'0+/0($ B)%/+'#/&07$D,/"$ E&!-%$
clearly generate a conflict flag using the ma-
chinery described in the previous section (note 
that this would require a formalisation of the 




The ProcessSEER tool, implemented using the 
Eclipse environment, the STP BPMN model-
ling tool (;.1+5)%"<=>"8//1)"?1(#!/&4@"A?BC"
Modeller, 2009), the Prover9 theorem prover 
9@+G!0)H$3IIJ;$'0%$#,)$KGLCGAM$+&0#2&--)%$
0'#!2'-$ -'0(!'()$#&&-=/#$ 9N+,E/##)2$O$1!+,"H$
1996)), provides an adequate basis for semantic 
effect annotation of clinical process models, 
6'")%$&0$#,)$)P4)2/)0+)$<2&B$B&%)--/0($'0%$'0-
0&#'#/0($+'0+)2$#2/'-$42&#&+&-"$%)"+2/6)%$'6&5)7
The most compelling motivation for se-
mantic effect annotation of clinical process 
models is the detection of treatment conflicts, 
but there are other useful applications for this 
B'+,/0)2F$'"$E)--7$K$>?@A$B&%)-$)P4-'/0"$
WHAT to do, but rarely HOW to do it (in any 
significant detail) or WHY an action is being 
D+6:&%"E7">")%.#+/-"!&/4"("5&/)#(#%"#&%(#4%-#"A?BC"5&/.%))"4/,%1")$/'+-6"#$%"5&%).&+5#+/-"/!"
(-#+9(-,&/6%-"4%,+.(#+/-




to a process model provide a mechanism for 
describing the HOW in considerably greater 
%)#'/-7$S)$6)-/)5)H$6'")%$&0$42)-/B/0'2F$)P-
perience, that this can help identify situations 
where specialists agree on (the broad picture of) 
a clinical protocol, but disagree on the detail of 
/#"$/B4-)B)0#'#/&07$N)B'0#/+$)<<)+#$'00&#'#/&0"$














Knowledge management in health care: an architec-







embs annual international conference Eclipse soa 
#//1)"51(#!/&4@"054-"4/,%11%&7 Retrieved from http://
EEE7)+-/4")7&2(*64B0*
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e&-/'%/"H$ R7H$ O$ R,&")H$K7$ e7$ 93II]H$ W)+)B6)2;7$
Correlating business process and organizational 
B&%)-"$ #&$B'0'()$ +,'0()7$ 80$?&/.%%,+-6)" /!" #$%"
Australasian conference on information systems.
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M/0H$ _7$ 93II\;7$ Semantic annotation for process 
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*+(")%4(-#+."+-#%&/5%&(0+1+#37$g04!6-/",)%$%&+#&2'-$
dissertation, Norwegian University of Science and 
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management systems: the case of post-stroke reha-
6/-/#'#/&07$Journal of Biomedical Informatics, 35(2), 
:3[h:[J7$%&/`:I7:I:]*N:^[3CIX]X9I3;II^I^C:
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<.+%-.%"(-,">551+.(#+/-)@"E7
V!<<&-&H$@7H$@'00'H$@7H$G&TT'H$Z7H$O$g2"/0&H$V7$
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